NFA
LGND icon

Nationwide Fund Advisors’s Ligand Pharmaceuticals LGND Stock Holding History

Nationwide Fund Advisors’s Portfolio LGND Stock Details LGND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-141,216
Closed -$12M – 1147
2017
Q3 		$12M Buy
141,216
+106,667
+309% +$8.45M 0.05% 544
2017
Q2 		$2.62M Buy
34,549
+5,881
+21% +$411K 0.01% 1313
2017
Q1 		$1.89M Sell
28,668
-66,159
-70% -$4.35M 0.01% 1421
2016
Q4 		$6.01M Sell
94,827
-23,676
-20% -$1.49M 0.03% 896
2016
Q3 		$7.54M Buy
118,503
+33,070
+39% +$2.43M 0.03% 768
2016
Q2 		$6.36M Buy
85,433
+1,171
+1% +$86.9K 0.03% 829
2016
Q1 		$5.65M Buy
84,262
+32,519
+63% +$1.98M 0.02% 870
2015
Q4 		$3.5M Buy
51,743
+33,494
+184% +$2.07M 0.02% 1111
2015
Q3 		$975K Hold
18,249
– – ﹤0.01% 1739
2015
Q2 		$1.15M Sell
18,249
-4,831
-21% -$264K ﹤0.01% 1772
2015
Q1 		$1.11M Sell
23,080
-919
-4% -$35.2K ﹤0.01% 1837
2014
Q4 		$797K Sell
23,999
-1,524
-6% -$49.6K ﹤0.01% 1926
2014
Q3 		$748K Buy
25,523
+32
+0.1% +$1.06K ﹤0.01% 1973
2014
Q2 		$991K Buy
25,491
+3,448
+16% +$140K ﹤0.01% 1869
2014
Q1 		$925K Sell
22,043
-43
-0.2% -$1.79K ﹤0.01% 1766
2013
Q4 		$725K Sell
22,086
-665
-3% -$21.7K ﹤0.01% 2049
2013
Q3 		$614K Buy
22,751
+1,296
+6% +$36.5K ﹤0.01% 2116
2013
Q2 		$501K Buy
+21,455
New +$386K ﹤0.01% 2016

Other funds holding LGND

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
DMK
David M. Knott $275M AUM 59.23% 1-Year Est. Return
CCMLC
Cardinal Capital Management LLC (Connecticut) Greenwich, Connecticut $365M AUM 18.32% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Nationwide Fund Advisors's LGND Position: Q4 2017 in Review

Nationwide Fund Advisors sold out of Ligand Pharmaceuticals (LGND) in Q4 2017, closing a stake of 141,216 shares — an estimated $12M sold.

Nationwide Fund Advisors first reported a position in LGND in Q2 2013 and held it in 18 quarters. The position peaked at $12M in Q3 2017. 298 funds tracked by Wall St. Rank hold LGND as of Q4 2017.

  • Nationwide Fund Advisors reported no remaining Ligand Pharmaceuticals position as of Q4 2017 after selling out during the quarter.
  • Nationwide Fund Advisors sold 141,216 Ligand Pharmaceuticals shares in Q4 2017, an estimated $12M.
  • Nationwide Fund Advisors first reported a position in Ligand Pharmaceuticals in Q2 2013 and held it in 18 quarters.
  • Nationwide Fund Advisors's Ligand Pharmaceuticals position peaked at $12M in Q3 2017.
  • 298 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q4 2017.

Based on Nationwide Fund Advisors's 13F filing for Q4 2017, filed 1 Feb 2018.